Pacira BioSciences, Inc. <PCRX.O>: Leerink Partners initiates coverage with market perform rating; price target $28
PCRX•Related News
D-Wave amends 8-K to disclose US Commerce Dept stock issuance at USD 14.09 a share
QBTS•
Fearless US stock market vulnerable to shocks as midterms loom
SPY•
US fixed 30-year mortgage rate climbs to highest since June 2025
TLT•
Nasdaq grants Iveda 180-day extension to regain $1 minimum bid price compliance
IVDA•
MannKind partners with Rose Pharma on inhaled rapid-acting GLP-1 weight-loss therapy
MNKD•